Pierre Fabre Pharmaceuticals (USA)

It was a pleasure representing Pierre Fabre Pharmaceuticals (USA) to talk about how we’re integrating Patient Experience into our organization. Thank you Jennifer Rabin and for the opportunity! #DeloitteIWG

On this Rare Disease Awareness Day, Pierre Fabre proudly re-affirms its dedication to rare diseases, including the rare condition known as post-transplant lymphoproliferative disorder. Epstein-Barr virus positive Post-Transplant Lymphoproliferative Disorder (EBV+ PTLD) is a rare disease, occurring after solid organ or haematopoietic stem cell transplant. 💙 At Pierre Fabre, we are committed to advancing research and supporting patients, healthcare professionals, and advocacy groups to address the challenges of EBV+ PTLD. 🌍 Together, we can make a difference for the rare disease community. #RareDiseaseDay #PTLDAwareness #ABrightJourney

On this International Rare Disease Day, Pierre Fabre Laboratories stands in solidarity with the rare disease community, reaffirming our commitment to developing innovative treatments and fostering meaningful partnerships. Rare diseases may be uncommon, but our dedication to addressing them is unwavering 💪. 🤝 In collaboration with the EspeRare foundation, we're investigating an innovative in-utero therapy candidate for XLHED, a genetic disorder impacting sweat glands, skin, hair, and teeth. 🤝 Additionally, we've partnered with Atara Biotherapeutics in the treatment of a rare post-transplant lymphoma (EBV+PTLD). Together, let's continue to support and raise awareness for those living with rare diseases 💙 #PierreFabre #NewWaysToCare #RareDiseaseDay #RareDiseases

📣Countdown to Rare Disease Day! 🦓The Pierre Fabre Pharmaceuticals Team encourages you to prepare to #ShowYourStripes in support of the 30 million Americans with a rare disease. 🌟Pierre Fabre Pharmaceuticals looks forward to celebrating #RareDiseaseDay alongside the National Organization for Rare Disorders and the entire rare disease community to recognize and support the millions of patients living with conditions that profoundly impact them and their families. We believe in creating access for and bringing innovative therapies to those living with rare conditions. #NewWaystoCare #PierreFabre #Innovation

As the Pierre Fabre Pharmaceuticals Team returns to day-to-day work, we reflect on the importance of scientific exchange and building a shared understanding that supports our work towards delivering new ways to care and therapies in oncology and rare diseases. #TANDEM25 #NewWaystoCare #Innovation #Pierre Fabre

Visit Pierre Fabre Pharmaceuticals at Booth #125. #TANDEM25 Exhibit Hall is open until 3 pm today! Our colleagues look forward to building meaningful connections and long-term relationships that are required to support groundbreaking innovation to patients in need. #NewWaystoCare #Innovation #PierreFabre

Visit Exhibit Hall 3 (HCC) at #TANDEM25 to discuss updated Phase 3 survival data for a novel allogeneic cell therapy in relapsed or refractory Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with Dr. Armin Ghobadi February 13th a 6:45 pm. #NewWaystoCare #Innovation #Pierre Fabre

Visit Pierre Fabre Pharmaceuticals at Booth 125! The #TANDEM25 Exhibit Hall is open and our colleagues look forward to connecting, learning and building the long-term relationships required to bring meaningful innovation to patients in need. #NewWaystoCare #Innovation #Pierre Fabre

Pierre Fabre Pharmaceuticals is thrilled to be on the ground at the #TANDEM25 Annual Meeting. Our colleagues are ready to engage with and learn from experts in hematopoietic cell transplantation, cellular therapy, and gene therapy from around the world. #NewWaystoCare #Innovation #Pierre Fabre

🤝 Behind every cancer diagnosis is a unique human story—stories of resilience, grief, and hope. People-centered care means seeing the whole person and meeting their unique needs with compassion and empathy. 💙At Pierre Fabre Pharmaceuticals we are driven by our belief that every time we care for a single person, we make the whole world better. As we recognize #WorldCancerDay we remain committed to nurturing the strong relationships required to co-create best-in-class patient education and programs that reflect the unique human stories behind every cancer diagnosis. #NewWaystoCare #UnitedByUnique #Oncology